Equities

Eli Lilly and Co

0Q1G:LSE

Eli Lilly and Co

  • Price (CHF)540.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 27 2023 15:18 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Eli Lilly and Co had net income fall -16.08% from 6.24bn to 5.24bn despite revenues that grew 19.56% from 28.54bn to 34.12bn over the same period.
Gross margin80.16%
Net profit margin17.08%
Operating margin20.80%
Return on assets10.48%
Return on equity51.15%
Return on investment14.92%
More ▼

Cash flow in USDView more

In 2023, Eli Lilly and Co increased its cash reserves by 36.36%, or 751.60m. The company earned 4.24bn from its operations for a Cash Flow Margin of 12.43%. In addition the company generated 3.50bn cash from financing while 7.15bn was spent on investing.
Cash flow per share8.54
Price/Cash flow per share94.58
Book value per share13.48
Tangible book value per share1.17
More ▼

Balance sheet in USDView more

Eli Lilly and Co has a Debt to Total Capital ratio of 67.02%, a lower figure than the previous year's 168.72%.
Current ratio1.35
Quick ratio1.03
Total debt/total equity2.05
Total debt/total capital0.6702
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)1.36%
Div growth rate (5 year)14.97%
Payout ratio (TTM)71.20%
EPS growth(5 years)12.51
EPS (TTM) vs
TTM 1 year ago		7.85
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.